Here are four notes:
1. Among the analysts covering the stock, the 12-month price target is $87.88.
2. On Nov. 4, 2016, Zacks issued AmSurg shares a “hold” rating.
3. AmSurg reported earnings per share of $1.13 last quarter.
4. In the third quarter, AmSurg surpassed analysts’ estimates of $770.2 million and generated revenue of $822.2 million.
More articles on surgery centers:
Marshfield Clinic Health System facing opposition for $35M proposal featuring surgery center — 6 points
Analysts rate Surgery Partners shares — 4 things to know
BlackRock Institutional Trust Company lowers AmSurg stake by 0.2% — 5 quick facts
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.